Lymphocytic Leukemia, Acute Clinical Trials

A listing of Lymphocytic Leukemia, Acute medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 79 clinical trials
AN UN-BLINDED INTRA-PATIENT COMPARISON OF TRANSBRONCHIAL FORCEPS BIOPSY AND CRYOBIOPSY FOR PERIPHERAL PULMONARY LESIONS

Both tools are currently available but have not been adequately compared. All patients will undergo both biopsy types and the success of providing a diagnosis will be compared.

  • 0 views
  • 19 Feb, 2024
  • 1 location
The Development of a Chatbot to Augment Population Hypertension Management

The purpose of this study is to design, implement, and evaluate a chatbot to support hypertension management communications between the clinical team who support UPHS' Employee Hypertension Program (EHP) and the patients - employees of UPHS. The study population will include all adult patients who are enrolled in the EHP …

  • 0 views
  • 19 Feb, 2024
  • 1 location
PRELIMINARY STUDY OF OPTICAL BIOMARKERS FOR NEURODEGENERATION IN CHRONIC CEREBROVASCULAR DISEASE

We will be recruiting 60 subjects in total: 30 healthy, 15 with known narrowing of the carotid artery, and 15 small vessel stroke. All subjects will undergo at least 1 optical blood flow monitoring session, and the non-healthy subjects will undergo an additional MRI.

  • 0 views
  • 19 Feb, 2024
  • 1 location
Improving Tobacco Treatment Rates for Cancer Patients Who Smoke

To achieve all of our research objectives, we plan to conduct a pilot study of a CDS intervention, exposing half of our clinician sample to the TUT Service+VM condition during cancer care workflow, and comparing important outcome measures to those observed among the half exposed to the current usual care …

  • 0 views
  • 19 Feb, 2024
  • 1 location
Bone Water and Mineralization Measured by Nuclear Magnetic Resonance

Labs will be done at the screening visit and at the 12 month visit to ensure that subjects are healthy to receive infusion. All study participants will receive 1200 mg of calcium and 1000 units of Vitamin D. DXA, pQCT and MRI will be repeated at 12 and 24 months.

  • 0 views
  • 19 Feb, 2024
  • 1 location
A Long-Term Safety Extension Study of Mavacamten (MYK-461) in Adults with Hypertrophic Cardiomyopathy Who Have Completed the MAVERICK-HCM (MYK-461-006) or EXPLORER-HCM (MYK-461-005) Trials (MAVA-LTE)

This is a multicenter study to evaluate the long-term safety and tolerability of mavacamten in participants with nHCM who completed MAVERICK-HCM through Week 24 and enroll into this study within 3 months. All participants will receive active study drug as described below, but their status (active or placebo) in the …

  • 0 views
  • 19 Feb, 2024
  • 1 location
Optimization of Clinical Trial Design in Cutaneous Lupus

A unique identification number will be assigned to each subject, and his/her questionnaire data. These numbers will be used throughout all data analysis and presentation of results.

  • 0 views
  • 19 Feb, 2024
  • 1 location
TapToSleep: Guided Behavioral Approaches for Insomnia in Older Adults

 The purpose of this study is to examine the effects of this smartphone-delivered behavioral treatment for insomnia in older adults. This is a remote telehealth study, which means that all study procedures are conducted online and/or by phone.

  • 0 views
  • 19 Feb, 2024
  • 1 location
Acute and Long-term Effects of E-Cigarette Aerosol Inhalation on Biomarkers of Endothelial Function and Vascular Reactivity

Each participant, from both cohorts, will undergo 2 MRIs and 2 blood draws, per visit. All participants will be compensated for time taken to participate in the study. Key eligibility criteria include men and women, ages 18-35 with a BMI of 18.5-30.

  • 0 views
  • 19 Feb, 2024
  • 1 location
A5369: HIV-1-Gag Conserved-Element DNA Vaccine (p24CE) as Therapeutic Vaccination in HIV-Infected Persons with Viral Suppression on Antiretroviral Therapy

A5369 is a phase I/IIa, randomized, double-blind, placebo-controlled study to evaluate the safety, immunogenicity, and efficacy of p24CE/full-length Gag DNA, as a therapeutic vaccine in HIV-1 infected persons. The study targets to enroll 40 participants. All participants are well-suppressed on ART, current CD4 T cell counts greater than 500 cells/mm3, …

  • 0 views
  • 19 Feb, 2024
  • 1 location